arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

InnovAge Holding Corp.

INNV
$11.18 ▲ +0.23 (+2.05%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
7 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

InnovAge Holding Corp. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.5B
Dividend Yield
Revenue Growth 11.8%
Op. Margin -3.5%
ROIC -8.0%
FCF / Share $0.20
Trailing P/E
Price / Book 6.4x
FCF Yield 1.8%
Debt / Equity 0.26
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$853.70M
↑ +11.8%
Net Income Profit after all expenses
$-30.31M
↓ -42.1%
Operating Margin Operating profit as % of sales
-3.5%
↓ -14.9% 22th
FCF / Share Free cash flow per share
$0.20
↑ +159.6%
Long-Term Debt Long-term obligations
$60.00M
↓ -9.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
27
Returns
32
Financial Health
51
Cash Quality
11

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 27 quarters